Modification of On-Column Oligodeoxynucleotides
A R T I C L E S
and eluted with 5-50% MeOH in H2O to give 4 (14 mg, 68%) as a
pale yellow solid (crystallized from MeOH/H2O): mp 242 °C (colored);
1H NMR (270 MHz, DMSO-d6) δ 11.72 (br s, 2H), 8.46 (s, 2H), 6.06
(dd, 1H, J ) 6.6 and 5.9 Hz), 5.23 (d, 1H, J ) 4.6 Hz), 5.17 (t, 1H,
J ) 4.6 Hz), 4.21 (m, 1H), 3.78 (m, 1H), 3.59 (m, 2H), 2.12 (m, 2H);
13C NMR (100 MHz, CDCl3) δ 161.30, 148.97, 145.86, 96.54, 87.57,
85.09, 76.47, 75.39, 69.66, 60.64, 40.37; FAB-LRMS m/z 503 (MH+).
Anal. Calcd for C22H22N4O10‚0.5H2O: C, 51.67; H, 4.65; N, 10.77.
Found: C, 51.42; H, 4.45; N, 10.65. UV (H2O) λmax 356.6 nm (ꢀ
19 500), 333.6 nm (ꢀ 28 900), 314.0 nm (ꢀ 26 800), 238.8 nm (ꢀ
25 900), 333.6 nm (ꢀ 21 200), ꢀ260 17 900.
Preparation of ArgoPore Resin 5 Containing an Aminooctyl
Linker. To a mixture of ArgoPore-NH2 (1.00 g, 280 µmol/g), dioxane
(10 mL), and Et3N (1.0 mL) was added a solution of p-nitrophenyl-
chloroformate (560 mg, 2.80 mmol) in dioxane (5 mL) at 0 °C, and
the mixture was kept for 12 h at room temperature. The solid support
was filtered and washed with CH2Cl2, and the remaining amino groups
were capped by treatment with Ac2O/pyridine (1:1, 10 mL) for 3 h.
After the solid support was filtered and washed with CH2Cl2, a solution
of 1,8-diaminooctane (288 mg, 2.0 mmol) in dioxane (10 mL) was
added, and the mixture was kept for 48 h at room temperature. The
resulting solid support 5 was filtered and washed with MeOH and CH2-
Cl2 and was dried under reduced pressure. The amount of the reactive
amino group on the support was estimated by picrate assay26,28 to be
145 µmol/g.
Preparation of Methylamino-Modified CPG 500 Resin 16. To a
suspension of CPG500 (500 mg, 90.0 µmol/g) in CH2Cl2 (5 mL) were
added Boc-sarcosine (34 mg, 0.18 mmol) and EDC (34 mg, 0.18 mmol),
and the mixture was kept for 8 h at room temperature. The resin was
filtered and washed with CH2Cl2, and the remaining amino groups were
capped by treatment with Ac2O/pyridine (1:1, 4 mL) for 3 h. After the
resin was filtered and washed with CH2Cl2, the Boc group was removed
by treatment with 50% TFA in CH2Cl2 for 1 h. The resulting resin 16
was filtered and washed with 5% iPr2NEt in CH2Cl2 (10 mL) and CH2-
Cl2 and was dried under reduced pressure. The amount of the methyl-
amino group on the resin was estimated by picrate assay26,28 to be 90.0
µmol/g.
the extended coupling time (300 s) of EdU phosphoramidite 11. After
completion of the synthesis of fully protected ODNs supported by resins,
a small amount of the each resin (approximately 2 mg) was treated
with concentrated NH4OH (12-14 and 24-28, room temperature for
2 h; 30, 55 °C for 12 h). After filtration of the resin, the filtrate was
concentrated in vacuo to give ODN1, ODN4, and ODN9 possessing a
5′-DMTr group, respectively. The resulting ODN1, ODN4, and ODN9
were used as references for the subsequent on-column modification
using the copper-catalyzed oxidative acetylenic coupling reaction. The
remaining resin-supported ODNs were stored at -30 °C.
General Procedure of the Acetylenic Coupling Reaction Using
Resin-Supported ODN. A solution of CuCl (5 mg, 50 µmol) and
TMEDA (15 µL, 100 µmol) in DMF (500 µL) was stirred for 30 min
under O2 atmosphere at room temperature. To the resin-supported ODN
(2 mg, containing 20-100 nmol of ODN) in a Valiant bond elute
reservoir tube (5 mL, equipped with a polystyrene filter at the base)
were added a reactant (15, 29a, 29b, or 29c, 10 µmol) and the
CuCl-TMEDA/DMF solution (500 µL), and the mixture was shaken
under O2 atmosphere at 50 °C for 24 h. The resin was washed with
DMF (1 mL × 3), 5% EDTA aq (1 mL × 3), H2O (1 mL × 3), and
CH3CN (1 mL × 3). The resulting resin was subjected to another cycle
of the coupling reaction (24 h) and washed. The resin was then treated
with concentrated NH4OH (12-14 and 24-28, room temperature for
2 h; 30, 55 °C for 12 h). After filtration of the resin, the filtrate was
concentrated in vacuo, and the residue was dissolved in H2O. This
solution was analyzed by reversed-phase HPLC, using a J’sphere ODS-
M80 column (4.6 × 150 mm, YMC) with a linear gradient of CH3CN
(from 23% to 41% over 20 min) in 0.1 M triethylammonium acetate
(TEAA, pH 7.0), and the yields were estimated from peak areas of the
HPLC chart.
Purification of ODNs for Measurement of MALDI-TOF/MASS
and Primer Extension Assay.18 The resulting ODNs after the
acetylenic coupling reaction were purified by reversed-phase HPLC,
using a J’sphere ODS-M80 column (10 × 150 mm, YMC) with a linear
gradient of CH3CN (from 23% to 41% over 20 min) in 0.1 M
triethylammonium acetate (TEAA, pH 7.0). Fractions were concen-
trated, and the residue was treated with 80% AcOH aq for 20 min at
room temperature. After successive coevaporation with H2O, the residue
was dissolved in H2O and washed with AcOEt (three times). The water
layer was concentrated in vacuo, and the residue was dissolved in H2O
and purified by reversed-phase HPLC using a J’sphere ODS-M80
column (10 × 150 mm, YMC) with a linear gradient of CH3CN (ODN1
and ODN4, from 23% to 41%; ODN2, ODN3, ODN5, and ODN6,
from 7% to 20%; ODN7a-c, ODN8a-c, and ODN9, from 7% to 41%
over 20 min) in 0.1 M triethylammonium acetate (TEAA, pH 7.0) to
give the corresponding ODNs without 5′-DMTr groups.
Preparation of Methylamino-Modified CPG 2000 Resin 17. In
the same manner as described for 16, treatment of CPG 2000 (500
mg, 23 µmol/g) with Boc-sarcosine (9 mg, 46 µmol) gave 17 (23 µmol/
g).
Preparation of Methylamino-Modified ArgoPore Resin 18. In the
same manner as described for 5, ArgoPore-NH2 (1.00 g, 280 µmol/g)
was treated with p-nitrophenylchloroformate (560 mg, 2.80 mmol),
followed by N,N′-dimethyl-1,6-diaminohexane (500 µL, 2.8 mmol) to
give 18 (220 µmol/g).
MALDI-TOF/MASS Spectra of ODNs.18 Spectra were obtained
on a Voyager-DE pro (PerSeptive Biosystems), and the observed
molecular weights supported their structure. ODN2: calculated mass,
C72H86N14O45P5 2022.4 (M - H); observed mass, 2021.7. ODN3:
calculated mass, C122H151N24O80P10 3543.4 (M - H); observed mass,
3544.4. ODN5: calculated mass, C72H86N14O45P5 2022.4 (M - H);
observed mass, 2022.9. ODN6: calculated mass, C122H151N24O80P10
3543.4 (M - H); observed mass, 3542.6. ODN7a: calculated mass,
C85H89N13O43P5 2135.6 (M - H); observed mass, 2136.8. ODN7b:
calculated mass, C80H97N15O42P5S 2127.6 (M - H); observed mass,
2127.9. ODN7c: calculated mass, C91H93N13O46P5 2259.7 (M - H);
observed mass, 2260.3. ODN8a: calculated mass, C85H89N13O43P5
2135.6 (M - H); observed mass, 2135.3. ODN8b: calculated mass,
C80H97N15O42P5S 2127.6 (M - H); observed mass, 2127.6. ODN8c:
calculated mass, C91H93N13O46P5 2259.7 (M - H); observed mass,
2261.8. ODN9: calculated mass, C148H162N46O76P11 4141.9 (M - H);
observed mass, 4142.5.
General Procedure of Attachment of Leader 3′-Nucleoside to
Resins 8, 9, and 19-23. To a solution of 6 (34 mg, 53.5 µmol) in
DMF (2 mL) were added EDC (10 mg, 53.5 µmol) and 16 (150 mg,
90 µmol/g), and the mixture was kept for 48 h at room temperature.
The solid support was filtered and washed with pyridine. The remaining
amino groups were capped by treatment with 0.1 M DMAP and 10%
Ac2O in pyridine. The resulting 19 was filtered and washed with EtOH
and acetone and was dried under reduced pressure. The loading amount
of the leader 3′-nucleoside unit was estimated by DMTr cation assay
to be 58 µmol/g. In the same manner as described for 19, resin-
supported leader 3′-nucleoside units 8 (6 µmol/g), 9 (50 µmol/g), 20
(8 µmol/g), 21 (49 µmol/g), 22 (7 µmol/g), and 23 (39 µmol/g) were
prepared.
Synthesis of ODNs.18 Resin-supported ODNs 12-14, 24-28, and
30 were prepared on an Applied Biosystems 392 DNA/RNA synthesizer
utilizing standard phosphoramidite chemistry at a 1.0 µmol scale. The
phosphoramidite monomers were used at a concentration of 0.1 M in
dry CH3CN. The standard DNA synthesis cycle was used, except for
Primer Extension Assay.18 A solution of template ODN (2 pmol)
and 5′-fluorescent primer ODN9 (1 pmol) in H2O (4 µL) was heated
at 100 °C for 3 min and slowly cooled to room temperature. The primer
(28) Gisin, B. F. Anal. Chim. Acta 1972, 58, 248-249.
9
J. AM. CHEM. SOC. VOL. 125, NO. 38, 2003 11551